subject: Aarkstore Enterprise---icad, Inc. (icad) - Financial And Strategic Analysis Review [print this page] iCAD, Inc. (iCAD) is a medical device company which is principally engaged in the development, production and marketing of scanners or digitizing systems that are used in converting photographic, printed, and hard copy images to digital form. It also provides CAD solutions to healthcare professionals and aids in cancer detection. iCAD operates principally in the United States, Europe, France, Bermuda, Canada, Mexico and Australia. The company is headquartered in Nashua, New Hampshire, the US. In October 2008, it introduced two new MRI products, namely, SpectraLook and CADvue.
iCAD, Inc. Key Recent Developments
Mar 10, 2010: US PTO Grants Patent To iCAD Lesion Metric
Mar 08, 2010: iCAD Granted US Patent On CAD Lesion Metrics That Enhance Clinical Information For Image Analysis Solutions
Feb 22, 2010: iCAD Reports Revenue Of $28.1 Million In 2009
Oct 28, 2009: iCAD Reports Total Revenue Of $7.1 Million In Q3 2009
Jul 29, 2009: ICAD Reports Total Revenue Of $5.7 Million In Q2 2009
This comprehensive SWOT analysis of iCAD, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
